FACIT backed Radiant Biotherapeutics announces closing of $8M seed round for cancer therapies

April 25, 2023 – Emerging from stealth mode, Radiant’s financing enables the Company to continue rapidly advancing its Multabodies that have application across multiple diseases including cancer.

Read More from FACIT backed Radiant Biotherapeutics announces closing of $8M seed round for cancer therapies